European Journal of Medicinal Chemistry · 2018 · 20 citations · 21 references
PharmacyMedicinal ChemistryPharmacologyCancer PharmacologyPharmacokinetics Of Anticancer AgentsStructure-activity RelationshipsOncology PharmacologyPharmacodynamics Of Anticancer AgentsPharmacodynamics Of Anticancer DrugsPharmacokinetics Of Anticancer DrugsQuantitative Structure-activity RelationshipsStructure-activity Relationship AnalysisAnticancer ActivityMedicinal HeterocyclesPharmacokinetic ParametersStereochemical Structure - Activity RelationshipStructure - Activity Relationship OptimizationStructure - Pharmacokinetic Relationship AnalysisStructure-activity Relationship Modeling
21
Establishment and characterization of a human prostatic carcinoma cell line (PC-3).
Kaighn Me, Narayan Ks, Yuko Ohnuki et al. · PubMed · 1979 · 1.6K citations
Isolation of a human prostate carcinoma cell line (DU 145)
Kenneth R. Stone, Don D. Mickey, Heidi Wunderli et al. · International Journal of Cancer · 1978 · 1.2K citations
Evaluation of MCF10A as a Reliable Model for Normal Human Mammary Epithelial Cells
Ying Qu, Bingchen Han, Yi Yu et al. · PLoS ONE · 2015 · 299 citations · Full text
Medicine, Cell Biology, Oncology +17
Soy and isoflavone consumption in relation to prostate cancer risk in China.
Marion M. Lee, Scarlett Lin Gomez, Jeffrey S. Chang et al. · PubMed · 2003 · 228 citations